Duke University
Durham, North Carolina, 27710, United States
Location status: Recruiting
Location contact
Nisha Dalal, MS CCC-SLP
CONTACT
Priya Kishnani, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06795152
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
Interested in participating?
Request Info0 year–90 year
All sexes
Observational
Durham, North Carolina, 27710, United States
Location status: Recruiting
Nisha Dalal, MS CCC-SLP
CONTACT
Priya Kishnani, M.D.
PRINCIPAL_INVESTIGATOR
The immediate goal of this research is to create a natural history database to collect information from individuals who have a rare GSD. A repository of clinical, laboratory, and biochemical information on individuals with a rare GSD will allow a more definitive description of the different subtypes to be developed, which will permit development of treatment strategies in the future.
Duke will be the only site where this study takes place. However, since these are rare disorders, participants who receive care at other institutions will be included. The investigators will collect retrospective data from patient charts on diagnosed individuals, as far back as necessary to capture the clinical course of their disorder. Prospective data collected from patient charts after enrollment will be captured as well. Participant's medical records will be continually reviewed for the duration of the study.
Data will be collected from medical records and will only pertain to clinically relevant information, including, but not limited to: demographic and diagnostic information, tissue biopsy results, medical and family history, review of systems, imaging studies, results of liver, muscle, and nerve function testing, and urine and blood laboratory results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational. Natural history study.
Time frame: through study completion, an average of 10 years
Contact information is provided by the study sponsor or research team.
Nisha Dalal, MS, CCC-SLP
CONTACT
Rebecca Koch, PhD, RDN
CONTACT
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07336394
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Beijing, China
View Trial DetailsNCT01793168
1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V
Sioux Falls, South Dakota, United States
View Trial DetailsNCT06813443
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Bologna, Emilia-Romagna/Bologna, Italy
View Trial DetailsNCT07614139
Carbohydrate Metabolism, Inborn Errors, Congenital Hyperinsulinism
Padova, Italy
View Trial Details